Note: This unit version has not been officially published yet and is subject to change!
CHNG5605: Bio-Products: Laboratory to Marketplace (2019 - Semester 2)
| Unit: | CHNG5605: Bio-Products: Laboratory to Marketplace (6 CP) |
| Mode: | Normal-Day |
| On Offer: | Yes |
| Level: | Postgraduate |
| Faculty/School: | School of Chemical and Biomolecular Engineering |
| Unit Coordinator/s: |
Mammucari, Raffaella
|
| Session options: | Semester 2 |
| Versions for this Unit: |
| Campus: | Camperdown/Darlington |
| Pre-Requisites: | None. |
| Brief Handbook Description: | The objectives of the course are to provide students with an overview of biochemical and pharmaceutical industry. It will give students an insight into drug delivery systems and formulation; how therapeutic drugs work; and a general overview of biochemical and pharmaceutical marketing. The challenges for commercialisation of innovative methods and/or biochemical and pharmaceutical products and aspects of intellectual property protection will be elaborated. Ultimately the aspects of Good Manufacturing Practice (GMP) and international legislation for marketing pharmaceutical products will be illuminated. Lectures in this course will be delivered by University of Sydney staff and by a number of visiting professional representatives from industry and government agencies. When you successfully complete this course you acquire knowledge about drug formulation, pharmaceutical processing including physical processes, legislation governing the bio-manufacturing and commercialisation of biochemicals and pharmaceuticals. The information would be beneficial for your future career in pharmaceutical manufacturing companies. Students are encouraged to engage in an interactive environment for exchange of information. This course will be assessed by quizzes, assignments, technical reports.This unit of study is offered as an advanced elective unit of study to final year undergraduate students. |
| Assumed Knowledge: | None. |
| Additional Notes: | This course is for Master degree students and also is offered as an elective course for fourth year students. . |
| Timetable: | CHNG5605 Timetable | |||||||||||||||
| Time Commitment: |
|
|||||||||||||||
| T&L Activities: | Project Work - own time: Projects and self assisted learning. Students are expected to spend about six hours of study outside the specified contact period. |
Learning outcomes are the key abilities and knowledge that will be assessed in this unit. They are listed according to the course goal supported by each. See Assessment Tab for details how each outcome is assessed.
(7) Project and Team Skills (Level 2)
1. Utilise team-working skills to review, analyse, and consolidate knowledge in a technical report about the manufacturing of a biomedical product.
(8) Professional Effectiveness and Ethical Conduct (Level 4)
2. Critically discuss the pharmacological basis of a biomedical product
3. Document compliance with good-manufacturing guidelines for biomaterials production
(6) Communication and Inquiry/ Research (Level 3)
4. Ability to write an in-deph technical report (20 pages).
(3) Problem Solving and Inventiveness (Level 3)
5. Undertake an evaluation of the potential market for new biomedical products
(2) Engineering/ IT Specialisation (Level 3)
6. Explain key terms, principles and issues of pharmaceutical and biomaterials manufacturing, including physical processes, GMP related issues, pharmaceutical marketing and clinical trials.
7. Analyse production requirements and determine appropriate manufacturing process stages for a given biomedical product
| Assessment Methods: |
|
||||||||||||||||||||||||||||||||||||||||||
| Assessment Description: |
Quiz. Four multiple-choice and short-answer tests are given on selected topics. The tests are open-book and include topics covered during classes and/or in suggested readings. Group Project. Groups will be nominated in week 3 and a class of therapeutic compounds will be assigned to each group. The groups will be asked to select a pharmacological active compound by week 4. The group report will be related to the compound of choice and will include the following tasks: 1. Pharmacological basis of the therapeutic ingredient selected 2. Market and IP survey 3. Formulation 4. Production aspects 5. Compliance to good manufacturing guidelines Each group will submit twice. The first submission is part of the ``Collaborative learning workshop`` activity. Each group will submit a Draft Report (10 pages submission deadline Friday week 8). The submission will be peer evaluated. Each student will revise two draft reports and provide feedback. Marks will be given for the the quality of the submission (Group Work - 10 marks) and for the quality of feedback (Individual Task - 5marks). The final report will have a maximum length of 20 pages excluding references and attachments and should be submitted both in hard copy format and electronically. All team members should participate to all sections of the report. Cooperation within groups will be assessed by peer evaluations (to be submitted on-line by SparkPlus). Each group will identify and approach aspects that are relevant to the topic. It is expected that students will demonstrate understanding of the principles involved and appropriate written presentation skills. On-line activity. An on-line activity requiring students to interact with the course material will be available. Participation will be graded. In-class activity (2 scheduled in weeks 8 and 11 - 2 marks each). Students will undertake a task related to the topic covered in class. “2 minutes course” activity a reflective task on course content. |
||||||||||||||||||||||||||||||||||||||||||
| Grading: |
|
||||||||||||||||||||||||||||||||||||||||||
| Policies & Procedures: | See the policies page of the faculty website at http://sydney.edu.au/engineering/student-policies/ for information regarding university policies and local provisions and procedures within the Faculty of Engineering and Information Technologies. |
| Recommended Reference/s: |
Note: References are provided for guidance purposes only. Students are advised to consult these books in the university library. Purchase is not required.
|
| Note on Resources: | https://cusp.sydney.edu.au/units/view-uv-page/uos_version_id/314630#schedule |
Note that the "Weeks" referred to in this Schedule are those of the official university semester calendar https://web.timetable.usyd.edu.au/calendar.jsp
| Week | Description |
| Week 1 | Pharmaceutical Drugs, Economics and Life Style |
| Introduction to the “Bio-Products: Laboratory to Marketplace” course | |
| Week 2 | Drug Discovery |
| Week 3 | Marketing Plan |
| Week 4 | Drug Delivery Systems1 |
| Week 5 | Drug Delivery Systems 2 |
| Week 6 | Sterilization processes |
| Week 7 | Pharmaceutical Processing -1 |
| Week 8 | Good Manufacturing Practices |
| Week 9 | Assessment Due: Collaborative learning workshop |
| Week 10 | Validation of analytical techniques |
| Week 11 | Pharmaceutical Processing -2 |
| Assessment Due: Group Project-Final Report | |
| Week 12 | Sigma Strategies |
| Week 13 | Reading Game Awards |
| Assessment Due: “2 minutes course” activity |
Course Relations
The following is a list of courses which have added this Unit to their structure.
Course Goals
This unit contributes to the achievement of the following course goals:
| Attribute | Practiced | Assessed |
| (7) Project and Team Skills (Level 2) | No | 0.75% |
| (8) Professional Effectiveness and Ethical Conduct (Level 4) | No | 28.13% |
| (6) Communication and Inquiry/ Research (Level 3) | No | 6.75% |
| (5) Interdisciplinary, Inclusiveness, Influence (Level 3) | No | 0% |
| (3) Problem Solving and Inventiveness (Level 3) | No | 10.69% |
| (4) Design (Level 3) | No | 0% |
| (2) Engineering/ IT Specialisation (Level 3) | No | 53.69% |
These goals are selected from Engineering & IT Graduate Outcomes Table 2018 which defines overall goals for courses where this unit is primarily offered. See Engineering & IT Graduate Outcomes Table 2018 for details of the attributes and levels to be developed in the course as a whole. Percentage figures alongside each course goal provide a rough indication of their relative weighting in assessment for this unit. Note that not all goals are necessarily part of assessment. Some may be more about practice activity. See Learning outcomes for details of what is assessed in relation to each goal and Assessment for details of how the outcome is assessed. See Attributes for details of practice provided for each goal.
